LivaNova
$63.79
12
-$0.84-1.3% Thursday 20:00
Statistics
Day High
64.92
Day Low
62.41
52W High
71.92
52W Low
32.48
Volume
666,827
Avg. Volume
794,786
Mkt Cap
3.49B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6MayExpected
Expected EPS
0.90328
Actual EPS
N/A
Financials
-17.47%Profit Margin
Unprofitable2.78BRevenue
-484.94MNet Income
Analyst Ratings
$74.50Average Price Target
The highest estimate is 81.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 83%
Hold 17%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LIVN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Abbott Laboratories
ABT
Mkt Cap214.96B
Boston Scientific
BSX
Mkt Cap149.24B
Smith & Nephew
SNN
Mkt Cap15.61B
Stryker
SYK
Mkt Cap136.19B
Zimmer Biomet
ZBH
Mkt Cap19.92B
Edwards Lifesciences
EW
Mkt Cap48.41B
Intuitive Surgical
ISRG
Mkt Cap189.4B
Hologic
HOLX
Mkt Cap16.45B
About
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Show more...
CEO
Mr. Vladimir A. Makatsaria
Employees
2900
Country
GB
ISIN
GB00BYMT0J19
Listings
0 Comments
Share your thoughts
FAQ
What is LivaNova stock price today?▼
The current price of LIVN is $63.79 USD — it has decreased by -1.3% in the past 24 hours. Watch LivaNova stock price performance more closely on the chart.
What is LivaNova stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange LivaNova stocks are traded under the ticker LIVN.
Is LivaNova stock price growing?▼
LIVN stock has risen by +3.14% compared to the previous week, the month change is a -2.25% fall, over the last year LivaNova has showed a +77.44% increase.
What is LivaNova market cap?▼
Today LivaNova has the market capitalization of 3.49B
When is the next LivaNova earnings date?▼
LivaNova is going to release the next earnings report on May 06, 2026.
What were LivaNova earnings last quarter?▼
LIVN earnings for the last quarter are 0.86 USD per share, whereas the estimation was 0.82 USD resulting in a +5.51% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is LivaNova revenue for the last year?▼
LivaNova revenue for the last year amounts to 2.78B USD.
What is LivaNova net income for the last year?▼
LIVN net income for the last year is -484.94M USD.
How many employees does LivaNova have?▼
As of April 04, 2026, the company has 2,900 employees.
In which sector is LivaNova located?▼
LivaNova operates in the Health Care sector.
When did LivaNova complete a stock split?▼
LivaNova has not had any recent stock splits.
Where is LivaNova headquartered?▼
LivaNova is headquartered in London, GB.